A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 8,392 shares of SGMO stock, worth $17,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,392
Previous 9,832 14.65%
Holding current value
$17,119
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$0.36 - $0.65 $518 - $936
-1,440 Reduced 14.65%
8,392 $3,000
Q1 2024

Apr 25, 2024

SELL
$0.42 - $1.38 $128 - $420
-305 Reduced 3.01%
9,832 $6,000
Q4 2023

Jan 30, 2024

SELL
$0.3 - $0.63 $245 - $514
-817 Reduced 7.46%
10,137 $5,000
Q3 2023

Oct 25, 2023

SELL
$0.58 - $1.47 $531 - $1,347
-917 Reduced 7.72%
10,954 $6,000
Q2 2023

Aug 07, 2023

SELL
$1.11 - $1.74 $21,976 - $34,450
-19,799 Reduced 62.52%
11,871 $15,000
Q4 2022

Feb 01, 2023

BUY
$2.77 - $5.07 $16,700 - $30,567
6,029 Added 23.51%
31,670 $99,000
Q3 2022

Nov 09, 2022

SELL
$4.27 - $6.39 $994 - $1,488
-233 Reduced 0.9%
25,641 $126,000
Q2 2022

Aug 09, 2022

SELL
$3.28 - $6.21 $4,483 - $8,489
-1,367 Reduced 5.02%
25,874 $107,000
Q1 2022

Apr 21, 2022

SELL
$5.23 - $7.82 $18,660 - $27,901
-3,568 Reduced 11.58%
27,241 $158,000
Q4 2021

Feb 01, 2022

SELL
$7.29 - $10.97 $4,344 - $6,538
-596 Reduced 1.9%
30,809 $231,000
Q3 2021

Nov 15, 2021

BUY
$9.01 - $12.01 $180 - $240
20 Added 0.06%
31,405 $283,000
Q2 2021

Jul 30, 2021

BUY
$10.17 - $12.64 $9,142 - $11,363
899 Added 2.95%
31,385 $376,000
Q1 2021

May 03, 2021

BUY
$10.88 - $17.05 $153,136 - $239,978
14,075 Added 85.77%
30,486 $382,000
Q2 2020

Jul 28, 2020

BUY
$6.21 - $11.83 $18,220 - $34,709
2,934 Added 21.77%
16,411 $147,000
Q1 2020

May 06, 2020

BUY
$5.05 - $8.85 $33,279 - $58,321
6,590 Added 95.69%
13,477 $86,000
Q2 2019

Jul 30, 2019

BUY
$8.75 - $13.03 $2,353 - $3,505
269 Added 4.06%
6,887 $74,000
Q1 2019

Apr 29, 2019

SELL
$7.72 - $12.81 $1,304 - $2,164
-169 Reduced 2.49%
6,618 $63,000
Q4 2018

Jan 25, 2019

BUY
$9.51 - $16.6 $14,759 - $25,763
1,552 Added 29.65%
6,787 $78,000
Q3 2018

Nov 09, 2018

BUY
$13.05 - $19.05 $6,838 - $9,982
524 Added 11.12%
5,235 $89,000
Q4 2017

Jan 31, 2018

BUY
$11.6 - $17.35 $27,422 - $41,015
2,364 Added 100.72%
4,711 $77,000
Q3 2017

Nov 08, 2017

BUY
$8.4 - $15.0 $19,714 - $35,205
2,347
2,347 $35,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $319M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.